Mr. Chris Jackson reports

DOSEOLOGY ANNOUNCES EXTENSION TO CLOSING OF PRIVATE PLACEMENT AND RESIGNATION OF OFFICER

Doseology Sciences Inc., further to its news release of March 30, 2026, has received a 45-day extension from the Canadian Securities Exchange to close its non-brokered private placement. The offering will consist of up to 3,225,806 units at a price of 62 cents per unit to raise aggregate gross proceeds of up to $2-million.

Additionally, the company announces that Tim Corkum has resigned as the company's president and chief operating officer, effective April 28, 2026. The company thanks Mr. Corkum for his contributions to the company and wishes him well in his future endeavours.

About Doseology Sciences Inc.

Doseology Sciences specializes in pouch-based oral stimulant and cognitive support products. The rapidly expanding oral stimulant pouch sector is gaining momentum as consumers seek modern, discreet alternatives to traditional delivery formats. Unlike combustible tobacco or vape products, oral stimulant pouches are smokeless and vapour free, providing an alternative delivery method without inhalation.

From a market perspective, the oral pouch category is experiencing strong global growth as consumers increasingly prioritize convenience, portability and format innovation. The pouch sector represents one of the most dynamic and high-growth areas in modern functional consumer products.

We seek Safe Harbor.